中信銀行(601998.SH):2025年小型微型企業貸款專項金融債券(債券通)發行完畢
格隆匯3月28日丨中信銀行(601998.SH)公佈,根據中國人民銀行《准予行政許可決定書》(銀許准予決字〔2025〕第5號),公司獲准發行金融債券,2025年金融債券新增餘額不超過600億元,年末金融債券餘額不超過4,000億元。本行此次發行的2025年小型微型企業貸款專項金融債券(債券通)(以下簡稱“本期債券”)已於2025年3月26日簿記建檔,並於2025年3月28日在全國銀行間債券市場發行完畢。
本期債券發行規模為人民幣300億元,品種為3年期固定利率債券,票面利率為1.92%。本期債券募集資金將專項用於發放小型微型企業貸款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.